Aesthetic

Skin, Soft Tissues, and Hair

Long-term Safety and Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines

Moy R, for the Reloxin Investigational Group (Moy-Fincher Med Group, Los Angeles, CA; et al) Arch Facial Plast Surg 11:77-83, 2009^§

Abstract

Objective

To evaluate the long-term safety of repeated administrations of a new botulinum toxin type A (Reloxin; Medicis Pharmaceutical Corp, Scottsdale, Arizona) in the treatment of moderate to severe glabellar lines.

Methods

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

25-Year Experience with Hemicorporectomy for Terminal Pelvic Osteomyelitis and Decompressive Therapies in Burns Photothermolysis for Skin Rejuvenation single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy Flaps for the Management of Malpositioned Implants After Augmentation Mammoplasty of Stitch Length on Wound Complications After Closure of Midline Incisions: A Randomized Controlled Trial

Stay updated, free articles. Join our Telegram channel

Join